Neogen Corporation Interest Income (Expense), Nonoperating, Net
Neogen Corporation (NEOG) reported Interest Income (Expense), Nonoperating, Net of $6.36 million for the 12-month period ending 2024-05-31, per its 10-K filed 2024-07-30.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2024-07-30
- Neogen Corporation interest income (expense), nonoperating, net for the quarter ending 2022-08-31 was $969.00K, a 377.34% increase year-over-year.
- Neogen Corporation interest income (expense), nonoperating, net for the quarter ending 2022-05-31 was $598.00K, a 394.21% increase year-over-year.
- Neogen Corporation interest income (expense), nonoperating, net for the quarter ending 2022-02-28 was $314.00K, a 6.80% increase year-over-year.
- Neogen Corporation interest income (expense), nonoperating, net for the quarter ending 2021-11-30 was $224.00K, a 59.64% decline year-over-year.
- Neogen Corporation interest income (expense), nonoperating, net for fiscal 2024 was $6.36M, a 100.95% increase from fiscal 2023.
- Neogen Corporation interest income (expense), nonoperating, net for fiscal 2023 was $3.17M, a 136.45% increase from fiscal 2022.
- Neogen Corporation interest income (expense), nonoperating, net for fiscal 2022 was $1.34M, a 20.86% decline from fiscal 2021.
- Neogen Corporation interest income (expense), nonoperating, net for fiscal 2021 was $1.69M, a 71.76% decline from fiscal 2020.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2024-05-31 | $6.36M 10-K · filed 2024-07-30 | ||||
| 2023-05-31 | $3.17M 10-K · filed 2024-07-30 | ||||
| 2022-08-31 | $969.00K 10-Q · filed 2022-09-30 | $1.57M derived: sum of 2 quarters · filed 2024-07-30 | $1.88M derived: sum of 3 quarters · filed 2024-07-30 | $2.10M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-05-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $912.00K derived: sum of 2 quarters · filed 2024-07-30 | $1.14M derived: sum of 3 quarters · filed 2024-07-30 | $1.34M 10-K · filed 2024-07-30 | $1.27M 10-K · filed 2022-07-27 |
| 2022-02-28 | $314.00K 10-Q · filed 2022-04-01 | $538.00K derived: sum of 2 quarters · filed 2022-04-01 | $741.00K 10-Q · filed 2022-04-01 | $862.00K derived: sum of 4 quarters · filed 2023-08-15 | |
| 2021-11-30 | $224.00K 10-Q · filed 2021-12-30 | $427.00K 10-Q · filed 2021-12-30 | $548.00K derived: sum of 3 quarters · filed 2023-08-15 | $842.00K derived: sum of 4 quarters · filed 2023-08-15 | |
| 2021-08-31 | $203.00K 10-Q · filed 2022-09-30 | $324.00K derived: sum of 2 quarters · filed 2023-08-15 | $618.00K derived: sum of 3 quarters · filed 2023-08-15 | $1.17M derived: sum of 4 quarters · filed 2023-08-15 | |
| 2021-05-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $415.00K derived: sum of 2 quarters · filed 2023-08-15 | $970.00K derived: sum of 3 quarters · filed 2023-08-15 | $1.69M 10-K · filed 2023-08-15 | $1.61M 10-K · filed 2021-07-30 |
| 2021-02-28 | $294.00K 10-Q · filed 2022-04-01 | $849.00K derived: sum of 2 quarters · filed 2022-04-01 | $1.57M 10-Q · filed 2022-04-01 | $3.18M derived: sum of 4 quarters · filed 2022-07-27 | |
| 2020-11-30 | $555.00K 10-Q · filed 2021-12-30 | $1.28M 10-Q · filed 2021-12-30 | $2.89M derived: sum of 3 quarters · filed 2022-07-27 | $4.49M derived: sum of 4 quarters · filed 2022-07-27 | |
| 2020-08-31 | $722.00K 10-Q · filed 2021-09-30 | $2.33M derived: sum of 2 quarters · filed 2022-07-27 | $3.93M derived: sum of 3 quarters · filed 2022-07-27 | $5.20M derived: sum of 4 quarters · filed 2022-07-27 | |
| 2020-05-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $3.21M derived: sum of 2 quarters · filed 2022-07-27 | $4.48M derived: sum of 3 quarters · filed 2022-07-27 | $5.99M 10-K · filed 2022-07-27 | |
| 2020-02-29 | $1.60M 10-Q · filed 2021-03-31 | $2.87M derived: sum of 2 quarters · filed 2021-03-31 | $4.38M 10-Q · filed 2021-03-31 | $5.77M derived: sum of 4 quarters · filed 2021-07-30 | |
| 2019-11-30 | $1.27M 10-Q · filed 2020-12-29 | $2.78M 10-Q · filed 2020-12-29 | $4.17M derived: sum of 3 quarters · filed 2021-07-30 | $5.51M derived: sum of 4 quarters · filed 2021-07-30 | |
| 2019-08-31 | $1.51M 10-Q · filed 2020-09-30 | $2.90M derived: sum of 2 quarters · filed 2021-07-30 | $4.24M derived: sum of 3 quarters · filed 2021-07-30 | $5.27M derived: sum of 4 quarters · filed 2021-07-30 | |
| 2019-05-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $2.73M derived: sum of 2 quarters · filed 2021-07-30 | $3.76M derived: sum of 3 quarters · filed 2021-07-30 | $4.68M 10-K · filed 2021-07-30 | |
| 2019-02-28 | $1.33M 10-Q · filed 2020-04-03 | $2.36M derived: sum of 2 quarters · filed 2020-04-03 | $3.29M 10-Q · filed 2020-04-03 | $4.01M derived: sum of 4 quarters · filed 2020-07-30 | |
| 2018-11-30 | $1.03M 10-Q · filed 2018-12-28 | $1.96M 10-Q · filed 2019-12-27 | $2.68M derived: sum of 3 quarters · filed 2020-07-30 | $3.20M derived: sum of 4 quarters · filed 2020-07-30 | |
| 2018-08-31 | $927.00K 10-Q · filed 2019-09-26 | $1.65M derived: sum of 2 quarters · filed 2020-07-30 | $2.17M derived: sum of 3 quarters · filed 2020-07-30 | $2.60M derived: sum of 4 quarters · filed 2020-07-30 | |
| 2018-05-31 | $721.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $1.25M derived: sum of 2 quarters · filed 2020-07-30 | $1.67M derived: sum of 3 quarters · filed 2020-07-30 | $2.04M 10-K · filed 2020-07-30 | |
| 2018-02-28 | $524.00K 10-Q · filed 2019-03-29 | $953.00K derived: sum of 2 quarters · filed 2019-03-29 | $1.32M 10-Q · filed 2019-03-29 | ||
| 2017-11-30 | $429.00K 10-Q · filed 2018-12-28 | $798.00K 10-Q · filed 2018-12-28 | |||
| 2017-08-31 | $369.00K 10-Q · filed 2018-10-05 | ||||
| 2017-05-31 | $838.00K 10-K · filed 2019-07-30 | ||||
| 2016-05-31 | $322.00K 10-K · filed 2018-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |